Capital World Investors Legend Biotech Corp Transaction History

Capital World Investors

  • $586 Billion
  • Q1 2024

A detailed history of Capital World Investors transactions in Legend Biotech Corp stock. As of the latest transaction made, Capital World Investors holds 2,385,960 shares of LEGN stock, worth $104 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,385,960
Previous 2,385,960 -0.0%
Holding current value
$104 Million
Previous $144 Million 6.78%
% of portfolio
0.02%
Previous 0.03%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
SELL
$57.25 - $69.74 $107,172 - $130,553
-1,872 Reduced 0.08%
2,385,960 $144 Million
Q3 2023

Nov 13, 2023
SELL
$63.16 - $76.5 $9,031 - $10,939
-143 Reduced 0.01%
2,387,832 $160 Million
Q2 2023

Aug 11, 2023
SELL
$46.28 - $75.01 $64,421 - $104,413
-1,392 Reduced 0.06%
2,387,975 $165 Million
Q1 2023

May 15, 2023
SELL
$43.42 - $57.37 $12,157 - $16,063
-280 Reduced 0.01%
2,389,367 $115 Million
Q4 2022

Feb 14, 2023
BUY
$38.8 - $55.46 $12,377 - $17,691
319 Added 0.01%
2,389,647 $119 Million
Q3 2022

Nov 14, 2022
SELL
$38.15 - $57.1 $97,091 - $145,319
-2,545 Reduced 0.11%
2,389,328 $97.5 Million
Q2 2022

Aug 15, 2022
BUY
$33.54 - $55.0 $5.97 Million - $9.78 Million
177,849 Added 8.03%
2,391,873 $132 Million
Q1 2022

May 16, 2022
BUY
$31.02 - $48.18 $31.7 Million - $49.2 Million
1,020,545 Added 85.51%
2,214,024 $80.5 Million
Q4 2020

Feb 12, 2021
BUY
$25.8 - $32.39 $4.56 Million - $5.73 Million
176,860 Added 17.4%
1,193,479 $33.6 Million
Q3 2020

Nov 13, 2020
BUY
$27.5 - $39.61 $10.1 Million - $14.5 Million
366,619 Added 56.4%
1,016,619 $31.4 Million
Q2 2020

Aug 14, 2020
BUY
$36.1 - $42.56 $23.5 Million - $27.7 Million
650,000 New
650,000 $27.7 Million

Others Institutions Holding LEGN

# of Institutions
213
Shares Held
63.6M
Call Options Held
1.09M
Put Options Held
525K
View Full List

About Legend Biotech Corp

LEGN Quotes by TradingView
  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $7.29B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Capital World Investors Portfolio

Follow Capital World Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital World Investors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email